Hearing loss in children with Fabry disease

被引:11
|
作者
Suntjens, E. [1 ,2 ]
Dreschler, W. A. [3 ]
Hess-Erga, J. [4 ]
Skrunes, R. [5 ,6 ]
Wijburg, F. A. [2 ,7 ]
Linthorst, G. E. [1 ,2 ]
Tondel, C. [2 ,7 ,8 ]
Biegstraaten, M. [1 ,2 ,9 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Amsterdam Lysosome Ctr Sphinx, Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Clin & Expt Audiol, Amsterdam, Netherlands
[4] Haukeland Hosp, Dept Ear Nose & Throat Head & Neck, Bergen, Norway
[5] Haukeland Hosp, Dept Med, Bergen, Norway
[6] Univ Bergen, Inst Clin Med, Bergen, Norway
[7] Univ Amsterdam, Acad Med Ctr, Dept Pediat, Amsterdam, Netherlands
[8] Haukeland Hosp, Dept Pediat, Bergen, Norway
[9] Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
关键词
ENZYME REPLACEMENT;
D O I
10.1007/s10545-017-0051-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Hearing loss (HL) is a well-known feature of Fabry disease (FD). Its presence and characteristics have mainly been studied in adult patients, while only limited data are available on the presence and degree of HL in children with FD. This prompted us to study hearing sensitivity in pediatric FD patients. Methods All available audiograms of the Dutch and Norwegian children with FD were retrospectively collected. First, hearing sensitivity was determined by studying hearing thresholds at low, high, and ultra-high frequencies in children with FD and comparing them to zero dB HL, i.e., healthy children. In addition, the presence and type of slight/mild HL (defined as hearing thresholds at low frequencies of 25-40 dB HL) and moderate to severe HL (hearing thresholds > 40 dB HL) at first visit were analyzed. If available, follow-up data were used to estimate the natural course of hearing sensitivity and HL in children with FD. Results One-hundred-thirteen audiograms of 47 children with FD (20 boys, median age at first audiogram 12.0 (range 5.1-18.0) years) were analyzed. At baseline, slight/mild or moderate to severe HL was present in three children (6.4%, 2 boys). Follow-up measurements showed that three additional children developed HL before the age of 18. Of these six children, five had sensorineural HL, most likely caused by FD. Compared to healthy children (zero dB HL), FD children showed increased hearing thresholds at all frequencies (p < 0.01), which was most prominent at ultra-high frequencies (> 8 kHz). Hearing sensitivity at these ultra-high frequencies deteriorated in a period of 5 years of follow-up. Conclusion A minority of children with FD show slight/mild or moderate to severe HL, but their hearing thresholds are poorer than the reference values for normal-hearing children. Clinical trials in FD children should demonstrate whether HL can be prevented or reversed by early treatment and should specifically study ultra-high frequencies.
引用
收藏
页码:725 / 731
页数:7
相关论文
共 50 条
  • [1] Hearing loss in patients with Fabry disease
    Limberger, A.
    Beck, M.
    Delgado-Sanchez, S.
    Keilmann, A.
    [J]. HNO, 2007, 55 (03) : 185 - 189
  • [2] Prognostic model for hearing loss in Fabry disease
    Aguiar, Patricio
    Warwick, Allison L.
    McKie, Mark
    [J]. MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S15 - S16
  • [3] Hearing loss in a family affected by Fabry disease
    Sergi, Bruno
    Conti, Guido
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 (03) : 370 - 374
  • [4] Hearing loss in Fabry disease: Data from the Fabry Outcome Survey
    Hegemann, S.
    Hajioff, D.
    Conti, G.
    Beck, M.
    Sunder-Plassmann, G.
    Widmer, U.
    Mehta, A.
    Keilmann, A.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (09) : 654 - 662
  • [5] Characterization of vertigo and hearing loss in patients with Fabry disease
    Maria Köping
    Wafaa Shehata-Dieler
    Dieter Schneider
    Mario Cebulla
    Daniel Oder
    Jonas Müntze
    Peter Nordbeck
    Christoph Wanner
    Rudolf Hagen
    Sebastian P. Schraven
    [J]. Orphanet Journal of Rare Diseases, 13
  • [6] Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease
    Ries, M.
    Kim, H. J.
    Zalewski, C. K.
    Mastroianni, M. A.
    Moore, D. F.
    Brady, R. O.
    Dambrosia, J. M.
    Schiffmann, R.
    Brewer, C. C.
    [J]. BRAIN, 2007, 130 : 143 - 150
  • [7] Characterization of vertigo and hearing loss in patients with Fabry disease
    Koeping, Maria
    Shehata-Dieler, Wafaa
    Schneider, Dieter
    Cebulla, Mario
    Oder, Daniel
    Muentze, Jonas
    Nordbeck, Peter
    Wanner, Christoph
    Hagen, Rudolf
    Schraven, Sebastian P.
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [8] Progressive hearing loss in Fabry’s disease: a case report
    Florian M. Barras
    Raphaël Maire
    [J]. European Archives of Oto-Rhino-Laryngology and Head & Neck, 2006, 263 : 688 - 691
  • [9] Hearing loss in Fabry disease:: the effect of α-galactosidase A replacement therapy
    Hajioff, D
    Goodwin, S
    Quiney, RE
    Zuckerman, J
    MacDermott, K
    Mehta, A
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 621 - 621
  • [10] Progressive hearing loss in Fabry's disease: a case report
    Barras, Florian M.
    Maire, Raphael
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2006, 263 (07) : 688 - 691